Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS??? DEFICIT (Details Narrative)

v3.24.1.1.u2
STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)
 3 Months Ended 12 Months Ended
Jan. 09, 2024
Jun. 02, 2023
Nov. 23, 2022
Oct. 22, 2021
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Class of Stock [Line Items]                
Preferred stock shares, authorized         10,000,000   10,000,000  
Preferred stock, par or stated value per share         $ 0.0001   $ 0.0001  
Preferred stock shares issued         32   32  
Preferred stock shares outstanding         32   32  
Common stock shares authorized         1,000,000,000   1,000,000,000  
Common stock par value         $ 0.0001   $ 0.0001  
Common stock shares outstanding         1,224,827   1,288,415  
Number of securities called by warrants             559,839  
Aggregate principal amount   $ 198,000 $ 145,200          
Shares cancelled 64,100              
Restricted stock             $ 50,000  
Share based compensation         $ 37,500 $ 37,500 $ 37,500 $ 37,500
Modification of warrants             352,965  
Convertible Promissory Note [Member]                
Class of Stock [Line Items]                
Number of securities called by warrants       11,250        
Debt maturity date, description       October 20, 2021 to October 20, 2022        
Stock issued during period shares       11,250        
Proceeds from issuance of common stock       $ 197,501        
Exercise price of warrants per share       $ 40.00        
Other expenses             $ 0 $ 147,720
Common Stock [Member]                
Class of Stock [Line Items]                
Number of securities called by warrants             279,920  
Conversion of stock, shares converted   31,075 24,200          
Series B Preferred Stock [Member]                
Class of Stock [Line Items]                
Preferred stock shares issued             32  
Conversion of common stock for Series A preferred stock, shares             161,684  
Preferred stock conversion, description             Each Series B Convertible Preferred Share converts into 5,025.1 shares of the Company’s common stock